Jeong Kang - Publications
Affiliations: | 2008-2012 | Pharmaceutical and Biomedical Sciences | University of Georgia, Athens, Athens, GA, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2020 | Jeong Y, Oh JG, Kang JK, Moon SR, Lee KK. Three-dimensional dose reconstruction-based pretreatment dosimetric verification in volumetric modulated arc therapy for prostate cancer. Radiation Oncology Journal. 38: 60-67. PMID 32229810 DOI: 10.3857/roj.2020.00066 | 0.304 | |||
2015 | Kang JY, Eggert M, Mouli S, Aljuffali I, Fu X, Nie B, Sheil A, Waddey K, Oldham CD, May SW, Amin R, Arnold RD. Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models. Pharmaceutical Research. 32: 852-62. PMID 25158648 DOI: 10.1007/S11095-014-1501-5 | 0.392 | |||
2011 | Kang JY, Costyn LJ, Nagy T, Cowan EA, Oldham CD, May SW, Arnold RD. The antioxidant phenylaminoethyl selenide reduces doxorubicin-induced cardiotoxicity in a xenograft model of human prostate cancer. Archives of Biochemistry and Biophysics. 515: 112-9. PMID 21906582 DOI: 10.1016/J.Abb.2011.08.008 | 0.582 | |||
Show low-probability matches. |